Insider Selling: St. Jude Medical CFO Sells 40,000 Shares of Stock (STJ)
St. Jude Medical (NYSE:STJ) CFO Donald Zurbay unloaded 40,000 shares of the stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $57.31, for a total value of $2,292,400.00. Following the sale, the chief financial officer now directly owns 9,731 shares in the company, valued at approximately $557,684. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
A number of research firms have recently commented on STJ. Analysts at RBC Capital raised their price target on shares of St. Jude Medical from $40.00 to $44.00 in a research note to investors on Thursday, October 17th. They now have an “underperform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, October 17th. They now have a $59.00 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of St. Jude Medical from $55.00 to $60.00 in a research note to investors on Thursday, October 17th. They now have an “outperform” rating on the stock. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the stock. St. Jude Medical has an average rating of “Hold” and a consensus price target of $49.80.
St. Jude Medical (NYSE:STJ) traded down 0.91% during mid-day trading on Wednesday, hitting $57.82. The stock had a trading volume of 1,875,983 shares. St. Jude Medical has a 52 week low of $30.25 and a 52 week high of $54.06. The stock’s 50-day moving average is $52.21 and its 200-day moving average is $46.01. The company has a market cap of $16.883 billion and a price-to-earnings ratio of 23.83.
St. Jude Medical (NYSE:STJ) last issued its quarterly earnings data on Wednesday, October 16th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.01. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the previous year, the company posted $0.83 earnings per share. The company’s revenue for the quarter was up .9% on a year-over-year basis. Analysts expect that St. Jude Medical will post $3.73 EPS for the current fiscal year.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.